Table 2 Symptoms reported by PCC participants at least 3 months after the acute COVID-19 episode
PCC+ (n = 139) | |
|---|---|
Constitutional, n (%) | |
Fatigue | 69 (49.7) |
Sleep disturbance | 3 (1.7) |
Dizziness | 9 (6.5) |
Cardiac, n (%) | |
Chest pain | 12 (8.6) |
Arrhythmia | 1 (0.7) |
Respiratory, n (%) | |
Dyspnea | 46 (33.1) |
Cough | 21 (15.1) |
Gastrointestinal, n (%) | |
Abdominal pain | 12 (8.6) |
Diarrhea | 7 (5.0) |
Musculoskeletal, n (%) | |
Joint pain | 28 (20.1) |
Myalgia | 19 (13.7) |
Skin rash | 9 (6.5) |
Neurological, n (%) | |
Anxiety and depression | 57 (41.0) |
Headache | 22 (15.8) |
Loss of taste /smell | 29 (20.9) |
Brain fog | 6 (4.3) |